SCHEMBL7975722

SCHEMBL7975722

Cc1nc2c(O)cccc2n1Cc1ccccc1

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TNF P01375 1/20 0.60
KDM4E B2RXH2 2/20 0.50
ALDH1A1 P00352 2/20 0.50
HTR6 P50406 1/20 0.50
MEN1 O00255 1/20 0.50
GAA P10253 1/20 0.50
MAPT P10636 1/20 0.50
PKM P14618 1/20 0.50
KMT2A Q03164 1/20 0.50
TDP1 Q9NUW8 1/20 0.50
GALR3 O60755 2/20 0.49
NR2F2 P24468 2/20 0.49
RAB9A P51151 1/20 0.49
DCTPP1 Q9H773 2/20 0.47
BRD4 O60885 2/20 0.47
TLR7 Q9NYK1 1/20 0.47
PLA2G2A P14555 1/20 0.46
HPGD P15428 1/20 0.45
TLR8 Q9NR97 1/20 0.45
TP53 P04637 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27442056 0.85 GALR3 (0.47) TNFKDM4EALDH1A1HTR6MEN1
SCHEMBL22533595 0.85 DCTPP1 (0.56) TNFKDM4EALDH1A1HTR6MEN1
SCHEMBL1701199 0.82 TNF (0.60) TNFKDM4EALDH1A1HTR6MAPT
SCHEMBL7978785 0.81 TLR8 (0.52) KDM4EALDH1A1MEN1GAAMAPT
SCHEMBL28076729 0.81 TNF (0.59) TNFKDM4EALDH1A1HTR6MEN1
Formic Acid SCHEMBL28717019 0.80 DCTPP1 (0.51) TNFKDM4EALDH1A1HTR6MEN1
SCHEMBL28076959 0.79 TNF (0.57) TNFKDM4EALDH1A1HTR6MEN1
SCHEMBL3164934 0.79 KDM4E (0.46) KDM4EALDH1A1MEN1KMT2ATDP1
SCHEMBL16372380 0.78 DCTPP1 (0.51) TNFKDM4EALDH1A1HTR6MEN1
SCHEMBL7965582 0.77 TNF (0.55) TNFHTR6MEN1MAPTKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115108994-B Tergolian intermediate and preparation method and application thereof 江苏威奇达药业有限公司 2024-05-31 CN claimed
CN-115108994-A Tegolrazan intermediate and preparation method and application thereof 江苏威奇达药业有限公司 2022-09-27 CN claimed
CN-115108994-B Tergolian intermediate and preparation method and application thereof 江苏威奇达药业有限公司 2024-05-31 CN disclosed
CN-115108994-A Tegolrazan intermediate and preparation method and application thereof 江苏威奇达药业有限公司 2022-09-27 CN disclosed
US-6194396-B1 ANTIALLERGENS; ANTIINFLAMMATION AGENTS; AUTOIMMUNE DISEASE; ANTISHOCK AGENTS; ANALGESICS; E.G., A 4 OR 7-PHENYLALKYLENE-OXYBENZIMIDAZOLE UNSUBSTITUTED OR SUBSTITUTED IN THE 1,2,3-POSITION WITH AN OXY, AMINO AND/OR THIO GROUP FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2001-02-27 US disclosed
US-6083961-A FOR PREVENTION AND/OR TREATMENT OF BRADYKININ OR ITS ANALOGUES MEDIATED DISEASES SUCH AS ALLERGY, INFLAMMATION, AUTOIMMUNE DISEASE, SHOCK, PAIN FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2000-07-04 US disclosed
EP-0774462-A1 HETEROCYCLIC COMPOUND FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1997-05-21 EP disclosed